We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News   Oct 19, 2017 | Original story written by Nathan Collins for Stanford University

 
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

Stanford scientists have developed a synthetic substitute for a drug derived from Bugula neritina, or spiral-tufted bryozoan. (Image credit: Fitzgerald Marine Reserve Docent/Creative Commons)

 
 
 

RELATED ARTICLES

What Pneumococcus Says to Make You Sick

News

This study of "bacterial linguistics," attempts to identify the "words" that bacteria use to communicate.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

The Making of Soldier Ants

News

Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE